Analysts Expect CAE Inc. (NYSE:CAE) Will Announce Quarterly Sales of $633.04 Million

Last updated on Sunday, June 13, 2021 | 2021 MarketBeat

Equities analysts expect CAE Inc. (NYSE:CAE) (TSE:CAE) to announce $633.04 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for CAE's earnings, with the highest sales estimate coming in at $659.28 million and the lowest estimate coming in at $606.80 million. CAE posted sales of $397.14 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 59.4%. The firm is expected to issue its next quarterly earnings report on Wednesday, August 11th.

On average, analysts expect that CAE will report full-year sales of $2.95 billion for the current fiscal year. For the next year, analysts anticipate that the firm will report sales of $3.54 billion, with estimates ranging from $3.51 billion to $3.56 billion. Zacks Investment Research's sales calculations are an average based on a survey of research firms that cover CAE.

CAE (NYSE:CAE) (TSE:CAE) last announced its quarterly earnings results on Tuesday, May 18th. The aerospace company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05. The firm had revenue of $894.30 million for the quarter, compared to analysts' expectations of $878.95 million. CAE had a negative net margin of 1.35% and a positive return on equity of 4.94%. The company's revenue was down 8.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS.

CAE has been the topic of a number of recent analyst reports. National Bank Financial raised shares of CAE from a "sector perform" rating to an "outperform" rating and upped their target price for the company from $41.00 to $43.00 in a research report on Monday, April 19th. Desjardins raised shares of CAE from a "hold" rating to a "buy" rating in a research report on Tuesday, March 16th. Zacks Investment Research raised shares of CAE from a "sell" rating to a "hold" rating in a research report on Friday, May 21st. TD Securities upped their target price on shares of CAE from $34.00 to $40.00 and gave the company a "hold" rating in a research report on Tuesday, March 2nd. Finally, Scotiabank decreased their target price on shares of CAE from $45.00 to $44.00 and set an "outperform" rating on the stock in a research report on Thursday, March 11th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. CAE presently has an average rating of "Buy" and an average price target of $39.40.

NYSE CAE opened at $31.72 on Friday. The firm has a 50-day moving average of $30.44. CAE has a 12 month low of $13.80 and a 12 month high of $32.09. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.28 and a quick ratio of 1.04. The firm has a market capitalization of $9.31 billion, a PE ratio of -264.31, a P/E/G ratio of 4.78 and a beta of 1.83.

Large investors have recently modified their holdings of the stock. Caisse DE Depot ET Placement DU Quebec lifted its position in shares of CAE by 161.6% during the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 24,604,237 shares of the aerospace company's stock worth $692,846,000 after purchasing an additional 15,200,000 shares during the last quarter. Artisan Partners Limited Partnership lifted its position in shares of CAE by 13.6% during the 1st quarter. Artisan Partners Limited Partnership now owns 4,140,310 shares of the aerospace company's stock worth $117,979,000 after purchasing an additional 496,170 shares during the last quarter. Fiera Capital Corp lifted its position in shares of CAE by 5.4% during the 4th quarter. Fiera Capital Corp now owns 3,968,739 shares of the aerospace company's stock worth $109,631,000 after purchasing an additional 201,887 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of CAE by 13.3% during the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,782,013 shares of the aerospace company's stock worth $135,433,000 after purchasing an additional 443,813 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its position in shares of CAE by 305.3% during the 1st quarter. Russell Investments Group Ltd. now owns 3,102,170 shares of the aerospace company's stock worth $88,385,000 after purchasing an additional 2,336,765 shares during the last quarter. 62.36% of the stock is currently owned by hedge funds and other institutional investors.

About CAE

CAE Inc, together with its subsidiaries, provides training solutions for the civil aviation, defence and security, and healthcare markets worldwide. The company's Civil Aviation Training Solutions segment provides training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation; flight simulation training devices; and ab initio pilot training and crew sourcing services.

Further Reading: P/E Growth (PEG)

Get a free copy of the Zacks research report on CAE (CAE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CAE (NYSE:CAE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What are Bollinger Bands?


7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.